Could a ‘European Medicines Infrastructure’ help solve market failures in pharmaceutical R&D?
European Science-Media Hub: interview with Massimo Florio about a new European approach to pharmaceutical policy.
“In response to the Covid-19 crisis, the European Union has increased its commitment to the EU public health agenda. It has strengthened the mandate of both the European Medicines Agency (EMA) and the European Centre for Disease Control and Prevention (ECDC), and it has established the European Health Emergency Preparedness and Response Authority (HERA). […]”
Click here to read the article.